Personalized Therapy for Multiple Myeloma

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology, Oncology
Cover of the book Personalized Therapy for Multiple Myeloma by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319618722
Publisher: Springer International Publishing Publication: October 30, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319618722
Publisher: Springer International Publishing
Publication: October 30, 2017
Imprint: Springer
Language: English

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides the clinician with concise, practical guidance on risk stratification and therapeutic decision making in patients with multiple myeloma.  In addition, the available clinical trial and research data are summarized into meaningful reviews and evidence-based recommendations for treatment are presented. The coverage encompasses all phases and forms of disease, including high-risk myeloma.

Over recent decades, greater understanding of the biology of myeloma has fostered the development of new, more effective drugs, leading to remarkable improvements in survival. To continue this momentum, several recent prospective trials have aimed to identify further potential therapeutic targets or to evaluate various combinations of anti-myeloma agents. The increasing abundance of management options makes the decision making complex in different phases of the disease. This book will offer the clinician valuable assistance in the choice and sequencing of therapies, highlighting the need for a personalized approach that reflects the growing recognition that myeloma is not one uniform disease.

More books from Springer International Publishing

Cover of the book Innovation Networks in the German Laser Industry by
Cover of the book Intelligent Decision Technologies 2017 by
Cover of the book Inside the Mind of the Entrepreneur by
Cover of the book 50 Years of Brown Dwarfs by
Cover of the book Party Politics in a New Democracy by
Cover of the book Intelligent Fixtures for the Manufacturing of Low Rigidity Components by
Cover of the book Biobanking in the 21st Century by
Cover of the book Uncertainty Quantification in Computational Fluid Dynamics and Aircraft Engines by
Cover of the book Future Intelligent Vehicular Technologies by
Cover of the book Centromeres and Kinetochores by
Cover of the book Frontiers in Algorithmics by
Cover of the book Optical Characterization of Plasmonic Nanostructures: Near-Field Imaging of the Magnetic Field of Light by
Cover of the book Learning and Intelligent Optimization by
Cover of the book The Circulation of Anti-Austerity Protest by
Cover of the book Carson McCullers in the Twenty-First Century by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy